In addition to pursuing our own activity, our ambition is to become a benchmark player in initiation and development of medical and paramedical companies. Our investments can relate to the development of drug candidates (BioTech) as well as medical devices (MedTech).
![](/images/content/fr/investissement/fonds-d-amorcage/neovacs-investissement-fonds-d-amorcage-01.jpg)
Neovacs has launched a seed fund dedicated to financing innovative companies in the seed stage of developing treatments for COVID 19 and more generally, the fight against pandemics. The chosen theme is: "Current and future pandemics: therapeutic strategies (vaccines, antivirals) against SARS COVID 2 and other natural microorganisms posing a global catastrophic biological risk."
Do not hesitate to contact us if you are looking for funding (seed / round A).